Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 3/20 | 0.39 |
| ▸ | DRD5 | P21918 | 3/20 | 0.39 |
| ▸ | DRD3 | P35462 | 3/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | PRF1 | P14222 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | CCR2 | P41597 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2509330 | 0.92 | HDAC6 (0.40) | HDAC6DRD2DRD5DRD3HTR1A | |
| SCHEMBL2509389 | 0.92 | PIK3CA (0.44) | HDAC6DRD2DRD5DRD3HTR1A | |
| SCHEMBL2509397 | 0.84 | HDAC6 (0.44) | HDAC6DRD2DRD5DRD3GRM5 | |
| SCHEMBL2505984 | 0.83 | HDAC6 (0.40) | HDAC6DRD2DRD5DRD3HTR1A | |
| SCHEMBL2508327 | 0.81 | HDAC6 (0.44) | HDAC6GRM5PRF1 | |
| SCHEMBL2510813 | 0.76 | BRD9 (0.40) | HDAC6DRD2DRD5DRD3HTR7 | |
| SCHEMBL2509402 | 0.75 | CCNT1 (0.39) | HDAC6DRD2DRD5DRD3HRH4 | |
| SCHEMBL2504269 | 0.75 | HDAC6 (0.44) | HDAC6GRM5 | |
| SCHEMBL2505706 | 0.73 | HDAC6 (0.42) | HDAC6GRM5PRF1 | |
| SCHEMBL2503427 | 0.72 | HDAC6 (0.43) | HDAC6GRM5PRF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8314120-B2 | Small molecule potentiators of metabotropic glutamate receptors | ABBOTT GMBH & CO. KG (DE) | 2012-11-20 | — | — | US | claimed |
| US-8314120-B2 | Small molecule potentiators of metabotropic glutamate receptors | ABBOTT GMBH & CO. KG (DE) | 2012-11-20 | — | — | US | disclosed |
| US-20110245247-A1 | NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS | ABBOTT GMBH & CO. KG (DE) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245247-A1 | NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS | GRIN2C, GRM3, GRM2 | HDAC6 2622/4885DRD2 218/4885DRD5 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.